Aspirin in people with dementia, long-term benefits, and harms: a systematic review.
Katrina Alice Southworth DavisDelia BisharaMariam MolokhiaChristopher MuellerGayan PereraRobert J StewartPublished in: European journal of clinical pharmacology (2021)
The review findings are limited because studies include only people with Alzheimer's-type dementia and lack confirmatory studies, although an increased risk of bleeding events is recognised. Further research that addresses the benefits and risks of aspirin in more representative groups of people with dementia is needed to guide prescribing decisions.